Efficacy and safety of sodium-glucose co-transporter-2 inhibitors in kidney transplant recipients with diabetes mellitus

被引:0
|
作者
Buckley, Sophieanne [1 ]
Subramaniam, Yuvanaa [1 ,2 ]
Mallik, Ritwika [1 ,3 ]
Mukuba, Dorcas [1 ]
Casabar, Mahalia [4 ]
Ali, Omer [4 ]
Byrne, Connor [4 ]
Chowdhury, Tahseen A. [1 ]
机构
[1] Royal London Hosp, Dept Diabet & Metab, 7th Floor,John Harrison House,Whitechapel, London E1 1BB, England
[2] Guys & St Thomas NHS Fdn Trust, Dept Diabet & Metab, London, England
[3] UCL, Ctr Obes Res, London, England
[4] Royal London Hosp, Dept Nephrol, London, England
关键词
D O I
10.1111/dme.15383
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [41] Sodium-glucose co-transporter-2 inhibitors in patients treated with immune checkpoint inhibitors
    Moran Gvili Perelman
    Rafael Y. Brzezinski
    Barliz Waissengrin
    Yasmin Leshem
    Or Bainhoren
    Tammi Arbel Rubinstein
    Maxim Perelman
    Zach Rozenbaum
    Ofer Havakuk
    Yan Topilsky
    Shmuel Banai
    Ido Wolf
    Michal Laufer-Perl
    Cardio-Oncology, 10
  • [42] Effectiveness of sodium-glucose co-transporter-2 inhibitors on ischaemic heart disease
    Shen, Yun
    Zhou, Jian
    Shi, Lizheng
    Nauman, Elizabeth
    Katzmarzyk, Peter T.
    Price-Haywood, Eboni G.
    Horswell, Ronald
    Chu, San
    Yang, Shengping
    Bazzano, Alessandra N.
    Nigam, Somesh
    Hu, Gang
    DIABETES OBESITY & METABOLISM, 2020, 22 (07): : 1197 - 1206
  • [43] Myeloproliferative Neoplasms and Sodium-Glucose Co-Transporter-2 Inhibitors: A Case Series
    Patir, Pusem
    Cerci, Kubra
    Kurtoglu, Erdal
    TURKISH JOURNAL OF HEMATOLOGY, 2024, 41 (02) : 130 - 132
  • [44] Effect of sodium-glucose co-transporter-2 inhibitors on the levels of serum asprosin in patients with newly diagnosed type 2 diabetes mellitus
    Jiang, Aijun
    Feng, Zhanrong
    Yuan, Lu
    Zhang, Ying
    Li, Qian
    She, Yuqing
    DIABETOLOGY & METABOLIC SYNDROME, 2021, 13 (01):
  • [45] Safety of Sodium-Glucose Co-Transporter 2 Inhibitors
    McGill, Janet B.
    Subramanian, Savitha
    AMERICAN JOURNAL OF CARDIOLOGY, 2019, 124 : S45 - S52
  • [46] Safety of Sodium-Glucose Co-Transporter 2 Inhibitors
    McGil, Janet B.
    Subramanian, Savitha
    AMERICAN JOURNAL OF MEDICINE, 2019, 132 (10): : S49 - +
  • [47] The effect of sodium-glucose co-transporter-2 inhibitors on markers of subclinical atherosclerosis
    Stachteas, Panagiotis
    Karakasis, Paschalis
    Patoulias, Dimitrios
    Clemenza, Francesco
    Fragakis, Nikolaos
    Rizzo, Manfredi
    ANNALS OF MEDICINE, 2023, 55 (02)
  • [48] Effects of Sodium-Glucose Co-Transporter-2 Inhibitors on Markers of Vascular Damage
    Kourtidou, Christodoula
    Rafailidis, Vasileios
    Varouktsi, Garyfallia
    Kanakis, Efthimios
    Liakopoulos, Vassilios
    Vyzantiadis, Timoleon-Achilleas
    Savopoulos, Christos
    Marinaki, Smaragdi
    Stangou, Maria
    Tziomalos, Konstantinos
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (03):
  • [49] Beyond the myocardium: Sodium-glucose co-transporter-2 inhibitors in heart failure
    Chilton, Robert J.
    DIABETES OBESITY & METABOLISM, 2021, 23 (05): : 1215 - 1218
  • [50] Effect of sodium-glucose co-transporter-2 inhibitors on right ventricular function in patients with type 2 diabetes mellitus: A pilot study
    Patoulias, Dimitrios
    Toumpourleka, Maria
    Katsimardou, Alexandra
    Zografou, Ioanna
    Stavropoulos, Konstantinos
    Imprialos, Konstantinos
    Karagiannis, Asterios
    Doumas, Michael
    Papadopoulos, Christodoulos
    KARDIOLOGIA POLSKA, 2022, 80 (06) : 696 - 698